{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:28:21Z","timestamp":1780100901694,"version":"3.54.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA041180"],"award-info":[{"award-number":["R01 DA041180"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA028874"],"award-info":[{"award-number":["T32 DA028874"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bbr.2021.113688","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T20:41:15Z","timestamp":1637959275000},"page":"113688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Adenosine Monophosphate-activated Protein Kinase (AMPK) in serotonin neurons mediates select behaviors during protracted withdrawal from morphine in mice"],"prefix":"10.1016","volume":"419","author":[{"given":"Darrell","family":"Eacret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Noreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Blendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2021.113688_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","author":"Strang","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbr.2021.113688_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7621","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.bbr.2021.113688_bib3","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.bbr.2021.113688_bib4","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019","author":"Mattson","year":"2021","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.bbr.2021.113688_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2019.07.027","article-title":"The negative affect of protracted opioid abstinence: progress and perspectives from rodent models","volume":"87","author":"Welsch","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113688_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopsych.2010.08.021","article-title":"Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine","volume":"69","author":"Goeldner","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113688_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archgenpsychiatry.2007.11","article-title":"Elevated brain serotonin turnover in patients with depression","volume":"65","author":"Barton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113688_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113688_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression Tim Bliss","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain."},{"key":"10.1016\/j.bbr.2021.113688_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpsychires.2005.07.009","article-title":"A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2021.113688_bib11","article-title":"Serotonergic neurons signal reward and punishment on multiple timescales","volume":"2015","author":"Cohen","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.bbr.2021.113688_bib12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.neuron.2014.02.010","article-title":"Dorsal raphe neurons signal reward through 5-HT and glutamate","volume":"81","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2021.113688_bib13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.celrep.2019.01.014","article-title":"Dorsal raphe dual serotonin-glutamate neurons drive reward by establishing excitatory synapses on VTA mesoaccumbens dopamine neurons","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbr.2021.113688_bib14","doi-asserted-by":"crossref","unstructured":"T. Jolas, E.J. Nestler, G.K. Aghajanian, Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: Association with an up-regulation of the cyclic AMP pathway, 1999. https:\/\/doi.org\/10.1016\/S0306\u20134522(99)00436\u20134.","DOI":"10.1016\/S0306-4522(99)00436-4"},{"key":"10.1016\/j.bbr.2021.113688_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2013.08.071","article-title":"Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus","volume":"254","author":"Lunden","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2021.113688_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00514","article-title":"Blockade of serotonin 5-HT2A receptors suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-treated mice","volume":"7","author":"Pang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113688_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.psyneuen.2011.10.002","article-title":"Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats","volume":"37","author":"Staub","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2021.113688_bib18","doi-asserted-by":"crossref","unstructured":"T. Jolas, E.J. Nestler, G.K. Aghajanian, Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: Association with an up-regulation of the cyclic AMP pathway, 1999. https:\/\/doi.org\/10.1016\/S0306\u20134522(99)00436\u20134.","DOI":"10.1016\/S0306-4522(99)00436-4"},{"key":"10.1016\/j.bbr.2021.113688_bib19","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399407000245","article-title":"Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes","author":"Lam","year":"2007","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbr.2021.113688_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2013.00036","article-title":"Serotonin and the regulation of mammalian energy balance","author":"Donovan","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2021.113688_bib21","doi-asserted-by":"crossref","DOI":"10.1210\/endo-125-5-2664","article-title":"Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats","author":"Bagdy","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2021.113688_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2008.04.007","article-title":"Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus","author":"Brunetti","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2021.113688_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2016.03.006","article-title":"Nutrient-induced glucagon like peptide-1 release is modulated by serotonin","author":"Ripken","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbr.2021.113688_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-019-0384-x","article-title":"Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation","author":"Leon","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2021.113688_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/0091-3057(81)90174-X","article-title":"Peripherally administered serotonin decreases food intake in rats","author":"Pollock","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113688_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5607\/en.2012.21.2.52","article-title":"AMP-Activated Protein Kinase (AMPK) and Energy-Sensing in the Brain","volume":"21","author":"Ramamurthy","year":"2012","journal-title":"Exp. Neurobiol."},{"issue":"Suppl 4","key":"10.1016\/j.bbr.2021.113688_bib27","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/ijo.2008.122","article-title":"AMP-activated protein kinase in the brain","volume":"32","author":"Ronnett","year":"2008","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbr.2021.113688_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","article-title":"AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs","volume":"26","author":"Hardie","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbr.2021.113688_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbr.2021.113688_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.isci.2018.10.006","article-title":"AMP-activated protein kinase is essential for the maintenance of energy levels during synaptic activation","volume":"9","author":"Marinangeli","year":"2018","journal-title":"IScience"},{"key":"10.1016\/j.bbr.2021.113688_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1464-x","article-title":"Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process","volume":"10","author":"Domise","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbr.2021.113688_bib32","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.cell.2011.07.039","article-title":"Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop","volume":"146","author":"Yang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2021.113688_bib33","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1073\/pnas.1707047115","article-title":"Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal","volume":"115","author":"Brynildsen","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2021.113688_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neuron.2005.05.005","article-title":"Mu-opioid receptor and CREB activation are required for nicotine reward","volume":"46","author":"Walters","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2021.113688_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12031-015-0500-2","article-title":"AMPK Plays a Dual Role in Regulation of CREB\/BDNF Pathway in Mouse Primary Hippocampal Cells","volume":"56","author":"Huang","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2021.113688_bib36","first-page":"801","article-title":"Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence","volume":"19104","author":"Turner","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113688_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.261","article-title":"The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies","volume":"7","author":"Amare","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113688_bib38","article-title":"The effect of metformin on morphine analgesic tolerance and dependence in rats","author":"Fatemi","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.bbr.2021.113688_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0754-9","article-title":"Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation","volume":"13","author":"Pan","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2021.113688_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2014.06.002","article-title":"Unpredictable chronic mild stress induces anxiety and depression-like behaviors and inactivates AMP-activated protein kinase in mice","volume":"1576","author":"Zhu","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2021.113688_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbr.2013.07.032","article-title":"The activation of adenosine monophosphate-activated protein kinase in rat hippocampus contributes to the rapid antidepressant effect of ketamine","volume":"253","author":"Xu","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113688_bib42","article-title":"Neurocircuitry of addiction","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2021.113688_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/15360288.2012.734905","article-title":"Characterization of prescription opioid abuse in the United States: focus on route of administration.","volume":"26","author":"Kirsh","year":"2012","journal-title":"J. Pain. Palliat. Care Pharmacother."},{"key":"10.1016\/j.bbr.2021.113688_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2006.05.022","article-title":"Motives, diversion and routes of administration associated with nonmedical use of prescription opioids","author":"McCabe","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.bbr.2021.113688_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI33946","article-title":"Making a bad thing worse: adverse effects of stress on drug addiction","author":"Cleck","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2021.113688_bib46","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0504510102","article-title":"A genetic approach to access serotonin neurons for in vivo and in vitro studies","volume":"102","author":"Scott","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2021.113688_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2021.113688_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/JCI76261","article-title":"Cell-specific translational profiling in acute kidney injury","author":"Liu","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2021.113688_bib49","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.0901800106","article-title":"Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior","volume":"106","author":"Mague","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2021.113688_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113688_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-4328(01)00452-1","article-title":"Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice","author":"Carola","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113688_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25 years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113688_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010404","article-title":"Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice","author":"Isingrini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2021.113688_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2021.113688_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.bbr.2021.113688_bib56","doi-asserted-by":"crossref","DOI":"10.3791\/3769","article-title":"The tail suspension test","author":"Can","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbr.2021.113688_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12806","article-title":"Neurobehavioral effects of neonatal opioid exposure in mice: influence of the OPRM1 SNP","author":"Robinson","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbr.2021.113688_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025932118","article-title":"Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy","author":"Drake","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2021.113688_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/JCI133982","article-title":"Brain-specific repression of AMPK\u03b11 alleviates pathophysiology in Alzheimer\u2019s model mice","author":"Zimmermann","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bbr.2021.113688_bib60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55523.sa2","article-title":"A single-cell transcriptomic and anatomic atlas of mouse dorsal raphe Pet1 neurons","author":"Okaty","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bbr.2021.113688_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1126\/science.aab4138","article-title":"Metabolism: AMP-activated protein kinase mediates mitochondrial fission in response to energy stress","volume":"351","author":"Toyama","year":"2016","journal-title":"Sci. (80-. )"},{"key":"10.1016\/j.bbr.2021.113688_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JMN:17:1:45","article-title":"AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation","volume":"17","author":"Culmsee","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2021.113688_bib63","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0504510102","article-title":"A genetic approach to access serotonin neurons for in vivo and in vitro studies","volume":"102","author":"Scott","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S. A."},{"key":"10.1016\/j.bbr.2021.113688_bib64","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.celrep.2014.08.037","article-title":"Serotonergic versus nonserotonergic dorsal raphe projection neurons: differential participation in reward circuitry","volume":"8","author":"Mcdevitt","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbr.2021.113688_bib65","doi-asserted-by":"crossref","unstructured":"M. Luo, J. Zhou, Z. Liu, Reward processing by the dorsal raphe nucleus: 5-HT and beyond, (n.d.). https:\/\/doi.org\/10.1101\/lm.037317.114.","DOI":"10.1101\/lm.037317.114"},{"key":"10.1016\/j.bbr.2021.113688_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2008.07.042","article-title":"Bidirectional translational research: Progress in understanding addictive diseases","author":"Kreek","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113688_bib67","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2021.113688_bib68","doi-asserted-by":"crossref","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.bbr.2021.113688_bib69","doi-asserted-by":"crossref","DOI":"10.1124\/mol.119.119107","article-title":"Bidirectional relationship between opioids and disrupted sleep: putative mechanisms","author":"Eacret","year":"2020","journal-title":"Mol. Pharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821005763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821005763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:31:07Z","timestamp":1759066267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432821005763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":69,"alternative-id":["S0166432821005763"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113688","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine Monophosphate-activated Protein Kinase (AMPK) in serotonin neurons mediates select behaviors during protracted withdrawal from morphine in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113688"}}